8-K: HealthEquity Reports Strong Year-End Growth in HSAs and Assets, Provides Business Outlook

HealthEquity announced a 9% increase in HSAs to 8.7 million and a 14% growth in HSA assets to $25.2 billion as of January 31, 2024, along with updated financial guidance and details for its upcoming Investor Day.

Summary

• HealthEquity reported a total of 8.7 million Health Savings Accounts (HSAs) as of January 31, 2024, representing a 9% increase year-over-year.
• The company's total accounts reached 15.7 million, a 5% increase compared to the previous year.
• HSA assets grew to $25.2 billion, a 14% increase from $22.1 billion the year before.
• The company saw record organic growth in new HSAs and total HSA assets in the fourth quarter.
• HealthEquity has revised its fiscal year 2024 revenue guidance to a range of $995 million to $1 billion.
• Net income for fiscal year 2024 is projected to be between $49 million and $52 million.
• Adjusted EBITDA for fiscal year 2024 is expected to be in the range of $364 million to $369 million.
• Non-GAAP net income for fiscal year 2024 is projected to be between $191 million and $195 million.
• The company reaffirmed its fiscal year 2025 outlook, projecting revenue between $1.140 billion and $1.160 billion and adjusted EBITDA between 38% and 39% of revenue.
• HealthEquity aims to double non-GAAP net income per share over the next three fiscal years.
• The company expects $14.3 billion of HSA cash to reprice over the next few years, with varying average annualized yields.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong growth metrics, raised guidance, and reaffirmed outlook. The company's focus on future growth and profitability is also encouraging.

Positives

• The company experienced strong growth in HSAs, total accounts, and HSA assets.
• Record organic growth in new HSAs and total HSA assets was achieved in the fourth quarter.
• The company has revised its fiscal year 2024 guidance upwards.
• HealthEquity reaffirmed its fiscal year 2025 outlook.
• Management has set a goal to double non-GAAP net income per share over the next three fiscal years.
• Investments in digital education and other innovations are showing positive results.

Negatives

• New HSAs from sales year-to-date decreased by 2%.
• New HSAs from acquisitions year-to-date decreased by 100%.

Risks

• The company faces risks related to the acquisition of the BenefitWallet HSA portfolio.
• There are risks associated with the company's ability to safeguard custodial assets.
• The company operates in a competitive and rapidly evolving industry.
• The company is dependent on the continued availability of tax-advantaged HSAs.
• There are risks related to cybersecurity breaches and data interruptions.
• The company is subject to various laws and regulations.
• The company relies on partners and third-party vendors.
• The company relies on its management team and key team members.

Future Outlook

HealthEquity has provided updated guidance for fiscal year 2024 and reaffirmed its outlook for fiscal year 2025, with a goal to double non-GAAP net income per share over the next three fiscal years. The company also provided a schedule for HSA cash repricing.

Management Comments

• President and CEO Jon Kessler stated that the company's investments in digital education and other innovations are paying off.
• Executive Vice President and CFO James Lucania noted that the strong fourth quarter sales performance allows the company to raise and narrow guidance for fiscal 2024 and maintain its fiscal 2025 outlook.

Industry Context

HealthEquity's performance reflects the growing adoption of Health Savings Accounts as a key component of consumer-directed healthcare. The company's growth in HSA assets and accounts aligns with the broader trend of increasing consumer responsibility for healthcare costs.

Comparison to Industry Standards

• HealthEquity is the largest HSA custodian in the nation, making direct comparisons challenging.
• Fidelity Investments and HSA Bank are also significant players in the HSA market, but their specific metrics are not directly comparable due to different reporting structures and business models.
• The 14% growth in HSA assets is a strong indicator of HealthEquity's market position and ability to attract and retain customers.
• The company's focus on digital education and innovation is consistent with industry trends towards enhancing user experience and engagement.

Stakeholder Impact

• Shareholders will likely view the strong growth and positive outlook favorably.
• Employees may be motivated by the company's success and growth prospects.
• Customers will benefit from the company's continued investment in digital education and innovation.
• Suppliers and partners will likely see increased business opportunities with the company's growth.

Next Steps

• The company will host its Investor Day conference on February 22, 2024.
• Management plans to present and meet with investors at the conference.
• The company will continue to focus on growing its HSA business and expanding its market position.

Key Dates

Keywords

Health Savings Accounts, HSA, HealthEquity, Financial Results, Fiscal Year 2024, Fiscal Year 2025, HSA Assets, Adjusted EBITDA, Non-GAAP Net Income, Investor Day